| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
SS Innovations International Inc.$3.98
-0.02 (-0.5%)
Market Cap
778.51 M
EPS
-0.05
P/E Ratio
-
Value Trade
515.17 K
SEC Financials
Q1 2026Dilution Risk
Revenue
11.10 M
R&D Expenses
995.44 K
Operating CF
-2.31 M
Total Assets
90.55 M
Total Liabilities
36.02 M
Equity
54.52 M
D/E Ratio
12,345
-3.95 %
Week
-14.88 %
1 Month
-13.94 %
3 Month
-33.84 %
6 Month
-95.16 %
5 Year
-97.41 %
All Time
Cash Data
Cash Position
24.01 M
Monthly Burn
771.00 K
Runway
28.6 mo
Burn Trend
SEC Filing
May 13, 2026
Overview
Volume
33.12 K
52 Week Range
3.02 - 11.87
% held by Insiders
81.28 %
% held by Institutions
0.87 %
Enterprise Value
768.72 M
Total Shares
200.02 M
Short %
0.37 %
Float Shares
35.40 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
2026-06-30 | SSi Mantra surgical robotic system | IND Clearance | IND | — | – | – | – |
2026-06-30 | SSi Mantra surgical robotic system | IND Clearance | IND | — | – | – | – |
2026-06-30 | SSi Mantra surgical robotic system | IND Clearance | IND | — | – | – | – |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
SSi Mantra | surgical procedures | — | 2025-06-03 | over 4,000 robotic surgeries without complications | SS Innovations to Ring the Nasdaq Opening Bell on Tuesday | |
SSi Mantra | surgical procedures | — | 2025-06-03 | over 4,000 robotic surgeries without complications | SS Innovations to Ring the Nasdaq Opening Bell on Tuesday | |
SSi Mantra | surgical procedures | — | 2025-06-03 | over 4,000 robotic surgeries without complications | SS Innovations to Ring the Nasdaq Opening Bell on Tuesday |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SSII
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SSII Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SSII▼ -10.9%on this news
SS Innovations Announces Completion of World's Longest-Distance Robotic Telesurgery Cardiac telesurgery performed by Dr. Sudhir Srivastava utilizing the SSi Mantra surgical robotic system from Guyana, at a line distance
SS Innovations International, Inc. announced a groundbreaking achievement in telesurgery with the successful completion of the world's longest-distance robotic cardiac surgery, performed by Dr. Sudhir Srivastava from Guyana on a patient in India, spanning approximately 12,500 miles. This procedure utilized the SSi Mantra surgical robotic system and marked a significant milestone in the company's mission to enhance global access to advanced surgical interventions. The achievement coincided with Guyana's 60th independence anniversary and illustrates the potential for technology to bridge geographical barriers in healthcare. The SSi Mantra has established itself as a unique platform for robotic cardiac telesurgery, with regulatory approvals in 14 countries.
Read more →SSIIWe Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2026 Nasdaq: SSII 2026 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities N
SS Innovations International, Inc. is showcasing its commitment to developing advanced, affordable, and accessible surgical robotic solutions. The company highlights its proprietary surgical robotic system, the SSi Mantra 3, and comprehensive suite of surgical instruments. With a strong presence in India and expansion plans into Europe and the US, SS Innovations is capitalizing on a growing total addressable market in surgical robotics. The company reports significant sales growth and has established an impressive installed base across multiple countries.
Read more →SSIISS Innovations Reports First Quarter 2026 Financial Results
SS Innovations International, Inc. reported a significant increase in revenue for Q1 2026, reaching $11.1 million, a 116.8% rise from the previous year. The company also saw a substantial improvement in gross profit and expanded its surgical robotic system installations. Despite a net loss, the company is optimistic about future growth, particularly with recent regulatory approvals and funding from a private placement.
Read more →SSIISS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the pat
SS Innovations International, Inc. successfully completed a landmark long-distance telesurgery utilizing its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console. The procedure was performed by Dr. Mohit Bhandari from Perth, Australia, on a patient located over 4,500 miles away in India during the Royal Australian College of Surgeons Annual Scientific Congress. This achievement highlights the capabilities of the SSi Mantra system, showcasing its potential to transform access to surgical care on a global scale. The company aims to make robotic surgeries more affordable and accessible.
Read more →SSIISS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System
SS Innovations has announced that its SSi Mantra surgical robotic system has successfully completed over 10,500 surgeries, including various specialties. The company has trained approximately 2,100 physicians and expanded its presence globally with over 200 systems installed in 11 countries. The CEO highlighted the system's advanced technology and commitment to making robotic surgery accessible.
Read more →SSIISS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026 Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion Fort Lauderdale, FL
SS Innovations announced the unveiling of several cutting-edge surgical robotic technologies at the SMRSC 2026 conference held in New Delhi. Key innovations include the SSi Vimana Aero, a drone-assisted surgical system for battlefield injuries, the SSi Avtara humanoid surgical platform, and the SSi Operion mobile operating room. These technologies aim to enhance accessibility and efficiency in surgical procedures across diverse environments. Furthermore, the conference saw a significant increase in attendance, supporting the growing interest in robotic surgery innovations.
Read more →SSIISS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026 Conference to Unite Global Leaders at the Forefront of Surgical Robotic Innovation Fort Lauderdale, FL
SS Innovations will host the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) from April 9-11, 2026, in New Delhi, India. This event aims to gather leading surgeons and innovative thinkers to discuss advancements in robotic and minimally invasive surgery. Attendance is expected to exceed previous conferences, with over 1,400 participants anticipated. The conference will showcase live procedures and new technologies to enhance surgical care and access.
Read more →SSIISS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
SS Innovations has received regulatory approval for its SSi Mantra surgical robotic system in Colombia, Oman, Sri Lanka, and Kenya. This approval enhances the company's position in underpenetrated markets, promoting affordable robotic surgery. The SSi Mantra has already been approved in eleven countries, with a significant number of surgeries performed, including specialized procedures.
Read more →SSII▲ +7.2%on this news
SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines Company surpasses milestone of 150 cumulative telesurgeries successfully performed with the SSi Mantra Fort L
SS Innovations announced that its SSi Mantra Surgical Robotic System has received approval for telesurgeries in Indonesia and the Philippines. The company has also surpassed the milestone of 150 successful telesurgeries, primarily conducted in India. The SSi Mantra enhances surgical capabilities by allowing remote operations and the sharing of expertise among physicians. Plans for further demonstration of the system's capabilities will occur at the upcoming Global Multi-Specialty Robotic Surgery Conference in New Delhi, where live telesurgeries will be performed.
Read more →SSII▼ -5.6%on this news
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results Strong growth in SSi Mantra installations, procedures and revenues Fort Lauderdale, FL
SS Innovations International, Inc. (Nasdaq: SSII) reported impressive financial results for Q4 and the full year 2025, highlighting significant growth in the installations and procedures of their SSi Mantra surgical robotic system. The company has expanded its market presence, particularly in India, and is making strides towards entering the U.S. and European Union markets. Additionally, a successful private placement raised approximately $18.6 million to support its growth initiatives. Future growth is anticipated as the company aims to enhance access to robotic surgery worldwide.
Read more →SSII▲ +5.4%on this newsshared move
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
SS Innovations International, Inc. has successfully completed a private placement, raising approximately $18.6 million. The funds will be used for working capital and to advance growth initiatives, particularly in India and preparations for entry into U.S. and EU markets. The company anticipates FDA review of its surgical robotic system by mid-2026.
Read more →SSII▲ +10.8%on this news
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
SS Innovations International, Inc. announced preliminary unaudited revenue for Q4 and full year 2025, expecting significant growth driven by increased sales of its SSi Mantra surgical robotic system. The company reported a 158% increase in its cumulative installed base. CEO Dr. Sudhir Srivastava expressed optimism about regulatory reviews and the company's commitment to expanding access to robotic surgery globally.
Read more →SSIISS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer Fort Lauderdale, FL
SS Innovations International, Inc. has appointed Milan Rao as its Global Chief Operating Officer and Chief Financial Officer, succeeding Naveen Kumar Amar. This newly created role comes as part of the company's strategy to reinforce its leadership team as it aims to expand its innovative surgical robotic technologies globally. Rao brings over thirty years of experience in technology and healthcare sectors and will work closely with the executive leadership during the transition period to define growth strategies and optimize operations.
Read more →SSII▲ +6.5%on this newsshared move
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets Smaller 5-millimeter instruments to be incorporated into the SSi Mantra s
SS Innovations International, Inc. has announced the completion of five new 5-millimeter surgical instruments to support robotic surgeries in pediatric and cardiac markets. These instruments can significantly improve access to surgical care for children, specifically targeting the 1.7 billion children and adolescents lacking timely interventions. The company aims to make robotic surgery more accessible for these underserved populations, with a focus on enhancing surgical outcomes during complex procedures. With the SSi Mantra surgical robotic system, SS Innovations plans to expand their global reach and capabilities.
Read more →SSIISS Innovations Submits 510(k) Premarket Notification to the FDA for the Company’s SSi Mantra Surgical Robotic System
SS Innovations International, Inc. has submitted a 510(k) premarket notification to the FDA for its SSi Mantra surgical robotic system, covering multiple surgical specialties. The company aims to introduce this cost-efficient technology to the U.S. market, targeting underserved patient communities. The SSi Mantra has already seen significant use globally, with plans for EU certification in 2026.
Read more →SSIISS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console
SS Innovations International, Inc. has successfully completed its first telesurgery using the SSi Mantra Tele Surgeon Console (TSC). This innovative console allows surgeons to perform procedures remotely, enhancing accessibility to surgical care. The TSC's compact design supports telesurgery from various settings, demonstrating its potential to revolutionize surgical practices.
Read more →SSIIWe Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation November 2025 Nasdaq: SSII 2025 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securiti
SS Innovations International, Inc. presented its vision to develop advanced, affordable, and accessible surgical robotic solutions. The company highlights its proprietary system, the SSi Mantra 3, alongside significant achievements in surgical procedures and installations. With a strong leadership team and plans for global expansion, the company reported robust revenue growth and an increasing mix of recurring revenues. However, there are forward-looking statements that involve known and unknown risks.
Read more →SSIISS Innovations Reports Third Quarter 2025 Financial Results
SS Innovations International, Inc. reported strong financial results for Q3 2025, highlighting significant revenue growth attributed to the SSi Mantra 3 surgical robotic system. The company has received regulatory approval in seven countries and is preparing for entry into the U.S. and EU markets. A recent human factors validation study at Johns Hopkins Hospital supports their upcoming FDA submission.
Read more →SSIISS Innovations to Participate in Upcoming Investor Conferences
SS Innovations International, Inc. has announced participation in two upcoming investor conferences: the UBS Global Healthcare Conference on November 11, 2025, and the Stifel 2025 Healthcare Conference on November 12, 2025. Company executives will be available for one-on-one meetings, and a live webcast of the Stifel presentation will be accessible on their website. The company aims to make robotic surgery more affordable and accessible globally.
Read more →SSII▼ -8.6%on this news
SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System
SS Innovations announced the successful completion of a human factors validation study for its SSi Mantra surgical robotic system at Johns Hopkins Hospital. The company plans to submit a 510(k) premarket notification to the FDA in Q4 2025, aiming for potential market clearance in early 2026. This marks a significant step towards making robotic surgery more accessible.
Read more →SSII▲ +15%on this news· ran to +27% by day 3shared move
We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2025 Nasdaq: SSII 2025 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securitie
SS Innovations International, Inc. presented a comprehensive overview of its advanced surgical robotic solutions, particularly emphasizing the SSi Mantra system. The company highlighted its growth trajectory, with over 6,000 successful surgeries and plans for expansion into European and U.S. markets. SS Innovations aims to maintain affordability and accessibility in surgical robotics, backed by a distinguished leadership team with a strong track record in the field. The firm operates in various countries and prepares for further global growth.
Read more →SSIISS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer
SS Innovations has appointed Naveen Kumar Amar as Chief Financial Officer, effective September 24, 2025. Amar succeeds Dr. Vishwa Srivastava, who served as Interim CFO. With over 25 years of experience in finance across various industries, Amar aims to enhance the company's financial operations and support its growth in the surgical robotics sector.
Read more →SSIISS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System
SS Innovations has successfully completed the first pediatric pyeloplasty telesurgery using its SSi Mantra robotic system. The procedure was performed remotely by Dr. Chandra Mohan Vaddi from nearly 1,000 miles away. This advancement highlights the potential of robotic surgery to improve precision and accessibility, particularly in underserved areas. The company aims to expand its capabilities in pediatric robotic surgery.
Read more →SSII▲ +9.9%on this news
SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit
SS Innovations International, Inc. has successfully completed its first robotic telesurgery using the MantraM mobile robotic telesurgery unit. The procedure, guided by Dr. Priya Bhave Chittawar, involved a complex hysterectomy performed remotely. This milestone aims to enhance access to advanced surgical care in underserved communities and facilitate training for medical professionals.
Read more →SSIISS Innovations Reports Second Quarter 2025 Financial Results
SS Innovations International, Inc. reported a record revenue of $10 million for Q2 2025, driven by increased sales of its SSi Mantra 3 surgical robotic system. The company's gross profit more than tripled compared to the previous year, reflecting significant growth and margin expansion. CEO Dr. Sudhir Srivastava highlighted plans for a 510(k) application to the FDA by September 2025, indicating a focus on expanding their market presence.
Read more →SSIISS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery
SS Innovations announced the successful completion of the world's first intercontinental robotic cardiac telesurgery, performed by Dr. Sudhir Srivastava. The procedure took place remotely from France to India, showcasing the capabilities of the SSi Mantra 3 surgical robotic system. This achievement highlights the potential for enhancing access to complex cardiac care worldwide.
Read more →SSII▲ +12.2%on this news· ran to +67% by day 3
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System Continuing strong procedure growth, including an upsurge in telesurgeries Fort Lauderdale, FL
SS Innovations International, Inc. has surpassed 100 installations of its SSi Mantra surgical robotic system in India and six other countries. The system has been used in over 5,000 surgical procedures, including cardiac and telesurgeries. The company's CEO highlighted the increasing demand and effectiveness of the SSi Mantra, which aims to make robotic surgery more accessible. SS Innovations plans to pursue FDA approval and continued expansion into new markets.
Read more →SSII▲ +13.3%on this newsshared move
SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of
SS Innovations International, Inc. announced the successful completion of the world's first robotic telesurgery for weight loss, utilizing its SSi Mantra 3 surgical system. Conducted over a distance of 560 miles, the surgery demonstrated high precision and seamless control, led by renowned surgeon Dr. Mohit Bhandari. The procedure employed advanced bariatric techniques aiming to improve metabolic health. Executives emphasized that this achievement bridges healthcare gaps and enhances access to specialized care, particularly in underserved regions.
Read more →SSII▼ -8.5%on this news· ran to +95% by day 3
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System Surgery performed by Dr. Juan Zuniga at Interhospital
SS Innovations International, Inc. announced the successful completion of the first robotic cardiac surgery in the Western Hemisphere using the SSi Mantra 3 surgical robotic system. Conducted by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador, the surgery involved the closure of an Atrial Septal Defect. Following the operation, Dr. Zuniga praised the system's ease of use and the effective surgical outcomes, highlighting the patient's positive recovery. This achievement marks a significant milestone for robotic surgery in the Americas.
Read more →SSIIWe Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2025 Nasdaq: SSII Forward - Looking Statements This Presentation contains forward - loo
SS Innovations International, Inc. is poised to enhance the surgical landscape with its innovative SSi Mantra 3 robotic system and an array of advanced surgical instruments. The company is strategically expanding globally, targeting markets in Europe and the US, and has reported significant clinical success, including over 4,000 surgeries. Its leadership team has extensive experience in surgical robotics, underscoring confidence in the company's future growth potential. However, forward-looking statements indicate uncertainties that could impact projected results.
Read more →SSIISS Innovations to Ring the Nasdaq Opening Bell on Tuesday
SS Innovations International, Inc. is set to ring the opening bell at Nasdaq MarketSite on June 3, 2025, in celebration of its recent uplisting. Dr. Sudhir Srivastava, the CEO, highlighted this event as a milestone for the company. SS Innovations has also achieved a significant accomplishment by completing over 4,000 robotic surgeries using its SSi Mantra system without complications. The company aims to expand the reach of its surgical robotic technologies globally, including new markets in the EU and the US.
Read more →SSII▼ -19.7%on this news· ran to -42% by day 1
SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System Fort Lauderdale, FL
SS Innovations International, Inc. has achieved a significant milestone by successfully performing over 4,000 surgeries with its SSi Mantra surgical robotic system. These surgeries encompass more than 100 types of procedures, including cardiac surgeries performed via telesurgery in India. The company emphasizes the quality and ease of use of its system, which is already cleared for use in seven countries. Additionally, SS Innovations is progressing toward gaining regulatory approval for its robotic system in the European Union and United States by 2025 and 2026, respectively.
Read more →SSIISS Innovations Reports First Quarter 2025 Financial Results Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 Fort La
SS Innovations International, Inc. (Nasdaq: SSII) reported first-quarter 2025 financial results, highlighting a record revenue of $5.1 million, driven by increased sales of its SSi Mantra 3 surgical robotic system. The company showcased a 40.8% year-over-year revenue growth, along with significant improvements in gross margin due to lower raw material costs. A De Novo application to the FDA is planned for July 2025, as SS Innovations aims to further expand its market presence, including pursuing FDA approval and CE Mark decisions. However, the company reported a notable net loss alongside high operating expenses.
Read more →SSIISS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy Fo
SS Innovations International, Inc. plans to submit a De Novo Classification Request to the FDA for the SSi Mantra 3 surgical robotic system in July 2025. The system has been used in over 3,800 surgeries without complications, supported by validated clinical data from a leading contract research organization. The application aims to facilitate the system's use in multiple surgical specialties including urology and cardiac surgery. Additionally, the company is pursuing CE Mark approval in the European Union.
Read more →SSIISS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends Fort Lauderdale, FL
SS Innovations International, Inc. has reiterated its guidance for the first quarter of 2025 and commented on second quarter order trends. The company's CEO expressed satisfaction with the growth of the business following its recent uplisting to Nasdaq. SS Innovations reports plans to maintain its momentum and achieve significant milestones throughout the year. The company’s financial results for the first quarter of 2025 are expected to be released around May 15, 2025.
Read more →SSIISS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL
SS Innovations International, Inc. has announced the appointment of Arvind Palaniappan as interim Chief Financial Officer, effective May 1, 2025. This leadership transition comes as the company is also in the process of identifying a permanent successor for the CFO position. Anup Sethi, who served as CFO for seven years, will continue to advise the company during this change. Dr. Sudhir Srivastava expressed confidence in Palaniappan's ability to manage financial operations effectively during this crucial period.
Read more →SSII▼ -7%on this news· ran to +32% by day 1
Fort Lauderdale, FL
SS Innovations International, Inc. (OTC: SSII) has announced its common stock will begin trading on The Nasdaq Capital Market on April 25, 2025. This uplisting is viewed as a significant milestone for the company as it aims to enhance market visibility and transparency while pursuing global expansion. SS Innovations is also seeking EU CE Mark and U.S. FDA approval for its SSi Mantra surgical robotic system, anticipated in late 2025 and early 2026, respectively. The company focuses on making robotic surgery more affordable and accessible worldwide.
Read more →SSII▲ +6.4%on this news
SS Innovations Achieves Significant Milestones in 2024 The Company's award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different type
SS Innovations, a developer of surgical robotic technologies, reported significant milestones for 2024, highlighting their SSi Mantra surgical robotic system which has performed over 3,500 surgeries and is authorized for more than 100 surgical procedures. The Company is focusing on securing regulatory approvals in the U.S. and Europe, expected by late 2025 or early 2026. Dr. Sudhir Srivastava, CEO, emphasized that these efforts will build a strong foundation for future growth as they aim to enhance access to affordable robotic surgery globally.
Read more →SSIISS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System The SSI Mantra 3 Surgical Ro
SS Innovations International, Inc. has successfully completed India's first North-to-South robotic cardiac telesurgery, utilizing its SSi Mantra 3 Surgical Robotic System. The procedure, which took place over a distance of 2,000 kilometers, involved closing a congenital heart defect in a 35-year-old patient. This achievement reflects significant advancements in making robotic surgical care more accessible across India. The company aims to continue bridging healthcare gaps and enhancing surgical technology through innovative solutions.
Read more →SSIISS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025 Fort Lauderdale, FL
SS Innovations International, Inc. has launched India's first Mobile Tele-Surgical Unit, the SSI MantraM, aimed at improving access to robotic surgery in underserved regions. This unit was unveiled during the Second Global Multi-Specialty Robotic Surgery Conference in Gurugram, attended by over 1200 medical professionals. The SSI MantraM integrates advanced surgical robotics with high-speed connectivity, enabling real-time collaboration and education for surgical teams. This innovation marks a significant step toward democratizing healthcare and enhancing the global landscape of robotic surgery.
Read more →SSIISS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025 Fort Lauderdale, Fla.
SS Innovations International has announced the launch of the 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025) set to take place in Gurugram, India. The conference will showcase advancements in robotic surgery, featuring live surgeries and presentations from leading experts. A highlight is the SSi Mantra 3 Robotic Surgical System, recognized for its capabilities in telesurgery. Additionally, the launch of the SSi Mantra Mobile Unit aims to provide access to advanced surgical care in underserved areas.
Read more →SSIISS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3 A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes
SS Innovations International has successfully performed the world's first robotic cardiac telesurgeries using its SSi Mantra 3 system, connecting its base in Gurugram, India, with Manipal Hospital in Jaipur. The initial procedure, focused on internal mammary artery harvesting, was achieved in just 58 minutes, showcasing exceptional precision. This milestone opens up new avenues for remote surgical care, particularly benefiting underserved populations by bridging geographical barriers. The SSi Mantra 3 system is the only one approved for telesurgery, marking a significant advancement in surgical technology and accessibility.
Read more →SSIISS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting Fort Lauderdale, FL.
SS Innovations International, Inc. has announced the completion of a re-audit of its consolidated financial statements by BDO India LLP, leading to restated financials that indicate improved financial performance. The company has also outlined its plans for uplisting its common stock to NASDAQ, believing it meets the necessary requirements without needing additional offerings. Furthermore, SS Innovations continues to expand its surgical robotics presence, completing over 2,500 procedures globally, including its first robotic cardiac surgery in Indonesia.
Read more →SSII▲ +6.3%on this newsshared move
India's First CDSCO Certified Robotic System for Telesurgery: SSI Mantra Leads the Way SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabili
SS Innovations has achieved a landmark status as the first company in India to receive CDSCO approval for its SSi Mantra robotic system, which features telesurgery and teleproctoring capabilities. This development is set to advance surgical practices and democratize access to specialized medical care in remote areas of India. The approval represents a significant milestone in the country's healthcare landscape, promising to reshape the delivery of advanced surgical treatments. SS Innovations aims to continue pushing the boundaries of medical technology to enhance healthcare accessibility worldwide.
Read more →SSIISS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia SS Innovations marks a milestone with the successful completion of Indonesia's first robotic cardiac surgery using its SSi Mantra Surgical
SS Innovations has successfully performed the first robotic cardiac surgery in Indonesia, utilizing its SSi Mantra Surgical Robotic System at Harapan Kita National Cardiac Hospital. Dr. Sudhir Srivastava and his team conducted various procedures, including CABG and ASD repairs, marking a significant advancement in Indonesia's cardiac healthcare. The achievement underscores the commitment of SS Innovations to enhance surgical accessibility and affordability, amid the growing need for advanced cardiac care in the region. This milestone could signal a comprehensive shift towards robotic surgical solutions in Indonesia's healthcare system.
Read more →SSII▲ +6.7%on this news
SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board Tim Adams to serve as Independent Board Director
SS Innovations International has welcomed Tim Adams as an Independent Board Director. With over 40 years of experience in the healthcare sector, Adams will enhance the company's strategic direction as it seeks FDA approval for its innovative SSi Mantra surgical system. His extensive background within major healthcare providers is expected to provide valuable insights as SS Innovations aims to expand its market presence. The company’s goal is to make robotic surgery more accessible and affordable worldwide, particularly as the regulatory approval process moves forward.
Read more →SSII▲ +11.8%on this newsshared move
Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System Fort Lauderdale, FL., September 23 2024 - SS Innovations International, Inc. (the Company
SS Innovations International, Inc. has celebrated the successful completion of over 2,000 surgical procedures using its SSi Mantra Surgical Robotic System, primarily in India. This milestone reflects the company's commitment to democratizing access to advanced surgical technologies, particularly in underserved regions. The SSi Mantra is praised for its precision and ergonomic design, facilitating minimally invasive surgeries and improving patient recovery times. The company is also seeking regulatory approvals to expand its market presence in the US and EU, aiming to enhance global access to its innovative solutions.
Read more →SSIISS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline Fort Lauderdale, FL.
SS Innovations International, Inc. has conducted a meeting with the FDA's CDRH to discuss the regulation of its SSi Mantra Surgical Robotic System. Following valuable feedback, the company plans to proceed with a de novo pathway for market submission, anticipating to apply for an investigational device exemption and conducting clinical trials in the U.S. and India. The company expects to secure its pre-market approvals by the end of 2025, provided there are no unanticipated issues that arise during the process.
Read more →SSIISS Innovations Welcomes "Father of Surgical Robotics" Dr. Fredric Moll to Board Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman.
SS Innovations has appointed Dr. Fredric Moll, the founder of Intuitive Surgical and a leader in surgical robotics, as Vice Chairman of its Board of Directors. His experience, particularly with the da Vinci system, is expected to bolster the company's vision of making robotic surgery more accessible and affordable worldwide. The recent launch of their SSI Mantra 3 robotic system signifies a step forward in multi-specialty surgical capabilities, with plans for FDA and EU regulatory approvals underway.
Read more →SSII▲ +1146.9%on this newsshared move
SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device
SS Innovations International, Inc. has achieved a significant milestone with the first sale of its SSi Mantra Surgical Robotic System in South America, specifically in Ecuador. The company received regulatory approval for clinical use of the system in May 2024, facilitating its entry into the market. Through a partnership with Ingemedica S.A., the robotic system will be utilized at Interhospital in Guayaquil City, enhancing surgical capabilities and access to advanced healthcare in the region. The SSi Mantra system is also undergoing regulatory processes in the U.S. and EU, with approvals expected in late 2025.
Read more →SSII▼ -91.5%on this newsshared move
SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock Fort Lauderdale, FL., August 30 2024 - SS Innovations International, Inc. (the Company" or "SS Innovations") (OTC: SSII), develo
SS Innovations International, Inc. has issued an update regarding its audit process and trade market status for its common stock. Following the dismissal of its prior accounting firm by the SEC, the company has engaged BDO India to conduct a re-audit of its financial statements for the years ended December 31, 2023, and December 31, 2022. Due to delays, its common stock has been relegated to the Expert Market Tier. However, the company assures that operations remain unaffected and has onboarded new independent directors to enhance its governance.
Read more →SSII▲ +12.3%on this news
SSI Mantra 3 An Advanced Surgical Robotic 2024 SS Innovations International, Inc. | Confidential and Proprietary | All Rights Reserved 1 Sudhir Prem Srivastava, MD Founder, Chairman and CEO SS Innovations Group Companies
SS Innovations International, Inc. is showcasing its SSI Mantra surgical robotic system, emphasizing its intent to create an advanced and cost-effective solution for surgeries. The presentation includes forward-looking statements that indicate potential challenges, particularly in achieving projected financial results amid known market uncertainties. India's current robotic surgery market is notably underdeveloped, with only a fraction of the global installed base, presenting both an opportunity and a challenge for SS Innovations to penetrate this market. The presentation encourages investor confidentiality and highlights the company's commitment to innovating healthcare solutions.
Read more →SSIIMeet The Latest Innovation In Robotic Surgery: The SSi Mantra-3 New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstra
SS Innovations International, Inc. is set to unveil its SSi Mantra-3 Surgical Robotic System in New York City from July 23 to July 25, 2024. This innovative system, which features up to five robotic arms, aims to increase the affordability and accessibility of robotic surgery globally. The demonstration will allow media, analysts, and the investment community to witness the advanced capabilities of the SSi Mantra-3, which has already received regulatory approval in India and is in the process of seeking approval in the US and EU. Leading robotic surgeons will discuss its potential impacts during the event.
Read more →SSIISSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made SSi Mantra SSi Mantra integ
SS Innovations International, Inc. announced that its SSi Mantra Surgical Robotic System has been installed at Baidya & Banskota Hospital in Kathmandu, marking the first surgical robot in Nepal. This development is set to enhance healthcare services in the region, improving surgical precision and patient recovery times. Hospital co-founders have expressed excitement about the impact this technology will have on patient care and the potential to transform surgical practices in Nepal.
Read more →SSII▼ -12.5%on this news
SS Innovations Designated "Outstanding Company" Finalist for Surgical Robotics Industry Awards 2024 Annual awards celebrate the best of the surgical robotics industry. Fort Lauderdale, FL.
SS Innovations International, Inc. (SSII) has been named a finalist in the 'Outstanding Company' category of the Surgical Robotics Industry Awards 2024. This recognition follows the successful implementation of their SSi Mantra Surgical Robotic System in 40 hospitals and their collaboration with Johns Hopkins University. The company has also reached a milestone of 100 robotic cardiac surgeries and is progressing toward regulatory approvals in the US and EU, anticipating FDA and CE Mark approval by 2025.
Read more →SSIISS Innovations' SSi Mantra Surgical Robotic System Approved for Use in Indonesia Fort Lauderdale, FL.
SS Innovations International, Inc. has announced that its SSi Mantra Surgical Robotic System has gained regulatory approval for clinical usage in Indonesia. This approval is seen as a significant step toward enhancing access to robotic surgical technologies in a country where these options have been limited. The system, which is designed to be cost-effective and versatile across various surgical procedures, aims to make robotic surgery more affordable for a larger population. Additionally, SS Innovations plans to pursue regulatory approvals in the United States and the European Union.
Read more →SSII▲ +6%on this news
SS Innovations Engages BDO as its new Auditor SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company's commitment to tra
SS Innovations International, Inc. has announced the engagement of BDO India LLP as its new independent auditor. The company believes this strategic step will support its plan to uplist its common stock to a National Securities Exchange while reflecting its commitment to financial transparency. In addition, SS Innovations reported notable operational success, with 32 installations of its SSi Mantra Surgical Robotic System and revenue of approximately $7 million for the quarter ended March 31, 2024. This highlights the company's dedication to expanding its innovative surgical technologies across a broad market, particularly in India.
Read more →SSII▲ +19.7%on this news
SS Innovations' SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion The SSi Mantra surgical robotic system has surpassed the 100 surgery milestone for robotic cardiac surg
SS Innovations announced that its SSi Mantra Surgical Robotic System has successfully completed over 100 robotic cardiac surgeries, marking a significant milestone. The company's innovative approach enables complex cardiac procedures to be performed with minimal invasiveness, promising advantages such as reduced trauma and quicker recovery times for patients. With plans to secure FDA and CE Mark approvals in 2025, SS Innovations aims to strengthen its position in the growing global market for robotic cardiac surgery, currently valued at $17.1 billion. The system has already been utilized in more than 1,000 procedures worldwide, establishing SS Innovations as a leader in this niche surgical field.
Read more →SSIISS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System Company's flagship SSi Mantra surgical device has now been used in more than 1000 procedures Fort Lauderd
SS Innovations announced the successful completion of the first pyeloplasty procedure on an infant using its SSi Mantra Surgical Robotic System at Preeti Urology & Kidney Hospital in Hyderabad, India. This milestone highlights the system's precision and adaptability for pediatric care. With over 1000 procedures performed using the system, SS Innovations aims to revolutionize affordable robotic surgery worldwide. The company is currently pursuing regulatory approvals in the U.S. and EU, expected in late 2024 or 2025.
Read more →SSIISS Innovations International Announces Q1 2024 Company Updates Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system Fort Lauderdale, FL.
SS Innovations International announced significant advances in Q1 2024, revealing that its SSi Mantra Surgical Robotic System has been successfully installed in 32 locations across India and has completed over 1,000 surgeries in various medical specialties. The company sold 8 surgical systems in the first quarter, generating projected revenues of approximately $7 million, surpassing the total revenue for 2023. The introduction of training sessions at the World Laparoscopy Hospital aims to enhance worldwide adoption of the SSi Mantra system among surgeons visiting the institute.
Read more →SSII▼ -24.7%on this news· ran to -35% by day 3
SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the
SS Innovations' SSi Mantra Surgical Robotic System has been successfully utilized for the world's first mitral valve replacement at the Narayana Institute of Cardiac Sciences in Bengaluru. This achievement marks a significant advancement in cardiac surgery, as the system is designed to make robotic surgery more affordable and accessible. The operation was performed by Dr. Nitin Kumar Rajput, with Dr. Sudhir Srivastava overseeing the procedure, which emphasized the benefits of minimally invasive surgery. The success of this surgery opens new avenues for cardiac treatment options in India and beyond.
Read more →SSII▲ +22%on this news· ran to +33% by day 3
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company's First Multi-Specialty Robotic Surgical Conference Remote coronary artery suturing performed on animal model via SS Innovations' telesurgery pla
SS Innovations International, Inc. showcased its telesurgery platform at the Multi-Specialty Robotic Surgical Conference in Gurugram, India, performing a remote coronary artery suturing procedure on an animal model. The demonstration was well-received by over 350 attendees, highlighting the capabilities of the SSi Mantra surgical robotic system. The conference featured various surgical procedures across multiple specialties, emphasizing the future integration of robotic surgery with artificial intelligence. SS Innovations is currently in the process of seeking regulatory approval for its system in the U.S. and EU, expected by 2024-2025.
Read more →SSII▲ +7%on this news
SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration Fort Lauderdale, FL.
SS Innovations International, Inc. has filed a pre-submission application with the FDA regarding its SSi MantraTM Surgical Robotic System. This follows acknowledgment from the CDRH on January 17, 2024. The SSi Mantra is notable for being the first surgical robotic system made in India and has already obtained regulatory approval in India and Guatemala. The company is now focusing on achieving further regulatory approvals in the United States and Europe, with a goal to make robotic surgery more affordable and widely accessible.
Read more →SSII▼ -8.5%on this newsshared move
SS Innovations Partners with India's Leading Medical Equipment Supplier, Medikabazaar Collaboration to facilitate sales of the SSi Mantra Surgical Robotic System to hospitals and medical facilities across India Fort Laud
SS Innovations International, Inc. has announced a strategic partnership with Medikabazaar to promote the SSi Mantra Surgical Robotic System in India. The collaboration aims to leverage Medikabazaar's extensive network for sales expansion across hospitals and medical facilities. The SSi Mantra, recognized as India’s first indigenously designed surgical robotic system, has been validated for use in over 40 surgical procedures and is poised for regulatory approval in the U.S. and Europe in the coming years. Both companies share a commitment to making advanced healthcare more accessible and affordable in India.
Read more →SSII▼ -6.9%on this news· ran to -20% by day 1
SS Innovations Achieves Significant Milestones in 2023 -Company's award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of s
SS Innovations International, Inc. reported significant milestones achieved in 2023, including over 550 surgeries performed by its SSi Mantra surgical robotic system. The company received regulatory approval from Guatemala and India's CDSCO, and established partnerships for distribution in various regions. Looking forward, SS Innovations aims to secure additional regulatory approvals in the United States and Europe by 2024-2025. The company's innovations focus on making robotic surgery more accessible globally.
Read more →SSIISS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities acr
SS Innovations has announced a strategic partnership with Surgical Lab to distribute the SSi Mantra Surgical Robotic System across Africa. The partnership aims to enhance access to robotic surgery in 27 countries, which is seen as a significant milestone for both companies. The SSi Mantra is notably affordable with broad surgical applications and has received regulatory approvals in several countries. There are plans for further expansion into the US and European markets in the coming years.
Read more →SSII▼ -8.8%on this news
S U D H I R S R I V A S T A V A I N N O V A T I O N S P V T . L T D . | C O N F I D E N T I A L I N F O R M A T I O N 1 SS INNOVATIONS PRODUCT PRESENTATION SUDHIR SRIVASTAVA INNOVATIONS PVT. LTD. - CONFIDENTIAL DISCLAIME
SS Innovations Pvt. Ltd. is underlining its commitment to advancing robotic surgery with the development of the SSi Mantra surgical robotic system, which aims to provide more cost-effective surgical solutions. Founded by renowned cardiac surgeon Dr. Sudhir Srivastava, the company has successfully completed two clinical trials and performed over 500 surgeries. The global market for surgical robotics is projected to grow significantly, and SS Innovations is positioning itself as a key player by targeting underserved populations, particularly in India. Regulatory approvals are ongoing, with expectations for FDA and CE certifications by 2024/2025.
Read more →SSIISS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr.
SS Innovations International has reached a milestone of 500 successful procedures using its SSi Mantra Surgical Robotic System. The surgeries include complex cardiac and urology oncology procedures performed by renowned surgeons in India. The system, which has gained regulatory approval in multiple countries, aims to make robotic surgery more accessible and affordable. The company plans to expand its regulatory approvals into the US and Europe in the coming years, highlighting its commitment to global healthcare advancements.
Read more →SSII▼ -10%on this news
SS Innovations Appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs Dr. Shokeen brings over 15 years of medical device experience, including time spent at Johnson & Johnson Fort Lauderdale, FL.
SS Innovations International, Inc. has announced the appointment of Dr. Sonia Shokeen as the new Head of Quality and Regulatory Affairs. Dr. Shokeen brings over 15 years of experience in the medical device sector, previously holding senior management roles at Johnson & Johnson and Medtronic. Her role will involve leading product lifecycle management and regulatory strategies, particularly as the company expands its reach for the SSi Mantra surgical robotic system, which has recently received regulatory approval in Guatemala. The company also plans to pursue FDA and CE Mark approvals in the coming years.
Read more →SSIISS Innovations Enters Licensing Agreement with Johns Hopkins University Company's flagship SSi Mantra surgical system now installed at the university's Baltimore campus Fort Lauderdale, FL.
SS Innovations International, Inc. (OTC: SSII) has entered a licensing agreement with Johns Hopkins University to install its SSi Mantra surgical robotic system at the Baltimore campus. This agreement includes collaboration at the Minimally Invasive Surgical Training and Innovation Center, where the latest advancements in surgery are taught. The partnership is expected to enhance research and the application of robotic surgical technologies. SS Innovations aims to expand access to robotic surgery across various medical fields while seeking regulatory approvals in the United States and Europe in the coming years.
Read more →SSII▼ -5%on this news· ran to -19% by day 3
SS Innovations Recognized on National News As India Celebrates Independence Day News channel, DD India, features SS Innovations' work in the field of medical technology as an example of Indian excellence Fort Lauderdale,
SS Innovations International, Inc. was featured on DD India, a major news channel, as part of India's 77th Independence Day celebrations. The company is recognized for its innovative, cost-effective surgical robotic technologies, specifically the SSi Mantra system, designed to improve access to advanced surgical care in India. The system is already clinically validated for over 40 types of procedures and has received regulatory approval in India, with further approvals pending in the U.S. and Europe.
Read more →SSIISS Innovations and Dr. Frederic Moll to Deliver Keynote Presentation at the MoneyShow Investment Masters Symposium, Las Vegas Dr. Moll, known as the father of robotic surgery', is the founder of Intuitive Surgical and cr
SS Innovations International, Inc. announced a keynote presentation by its CEO Dr. Sudhir Srivastava alongside Dr. Frederic Moll at the MoneyShow Investment Masters Symposium in Las Vegas. The focus will be on their flagship robotic surgical system, SSi Mantra, which aims to make robotic surgery more affordable and accessible. The SSi Mantra has been successfully validated in India and is expected to seek regulatory approvals from the FDA and CE in the coming years. This event represents a strategic opportunity to highlight their advancements in surgical robotics.
Read more →SSIISS Innovations Begins FDA and CE Regulatory Approval Processes for SSi Mantra Flagship Surgical Robotic Device Company retains Elexes, a regulatory and quality compliance firm with deep experience, to advance approval pr
SS Innovations International, Inc. has commenced the FDA and CE regulatory approval processes for its flagship surgical robotic device, the SSi Mantra. As part of its efforts, the company has engaged Elexes, a firm specializing in regulatory and quality compliance, to assist in navigation through the approval endeavors. The SSi Mantra is notable for being the first surgical system manufactured in India and has already received regulatory approval from the Indian CDSCO, being clinically validated in over 40 surgical procedures. The company aims to make robotic surgery more affordable and accessible globally.
Read more →SSIISS Innovations International, Inc. to Present at the Emerging Growth Conference on Wednesday
SS Innovations International, Inc. has announced its participation at the Emerging Growth Conference on July 12, 2023. During the event, CEO Dr. Sudhir Srivastava will present the company's flagship SSI Mantra surgical robotic system, which has been validated for use in a variety of surgical specialties. The conference is aimed at providing an interactive platform for investors and analysts to learn more about SS Innovations and its plans for future growth.
Read more →SSII▲ +55.6%on this news
SS Innovations International, Inc. S S I N N O V A T I O N S I N T E R N A T I O N A L I N C . - C O N F I D E N T I A L A N D P R O P R I E T A R Y 1 Improving lives through innovation and care. JUNE 2023 DISCLAIMERS S
SS Innovations International, Inc. (OTC: SSII) focuses on revolutionizing robotic surgery with its SSi Mantra system, which is the only cost-effective surgical robot offering versatile applications. The company aims to enhance global access to robotic surgery, particularly in underserved regions, and has completed over 200 successful surgeries. SSII's strong patent portfolio and recent merger with Avra Medical Robotics aim to leverage substantial market opportunities, especially in the growing Indian surgical robotics sector. However, the company's future financial projections carry inherent uncertainties.
Read more →SSIISS Innovations International, Inc. Provides Business Update; Celebrates Achievement of Significant Milestones Company's flagship SSi Mantra surgical robotic system utilized to perform successful complex cardiac, lung, he
SS Innovations International, Inc. has announced significant milestones in 2023, highlighting the successful use of its SSi Mantra surgical robotic system in over 200 surgeries. The system has been clinically validated in India for various surgical procedures, including complex cardiac and thoracic surgeries. The company's merger with AVRA Medical Robotics in April 2023 has further positioned it for growth. SS Innovations aims to expand its affordable robotic surgery solutions to underserved global populations.
Read more →SSIISS Innovations International, Inc. (f/k/a Avra Medical Robotics, Inc.) Commences Trading under "SSII" Ticker Symbol and Provides Corporate Update SSII is a Developer of Innovative , Affordable and Accessible Surgical Rob
SS Innovations International, Inc. has begun trading under the ticker symbol 'SSII' on OTC Markets, marking a significant milestone for the company. The firm focuses on making robotic surgery more affordable and accessible globally and has reported successful training of surgeons and surgeries completed with its SSI Mantra Surgical Robotic System. The company is planning to develop additional technologies, such as Mixed Reality based applications, with an emphasis on growth in international markets and FDA/CE approval processes. This update reflects SS Innovations' commitment to advancing surgical technologies.
Read more →SSIIAVRA Medical Robotics Announces Closing of Merger with CardioVentures Announces Management Changes and Name Change to SS Innovations International, Inc. Fort Lauderdale, FL
AVRA Medical Robotics, now SS Innovations International, Inc. (SSII), has completed its merger with CardioVentures, which includes a reverse stock split. The merger aims to enhance SSII's focus on innovative surgical robotics and expand its global presence. Management changes were implemented alongside the merger, with new leadership assuming vital roles in the company. This transition represents a significant shift in SSII's strategy towards making robotic surgery more accessible worldwide.
Read more →SSIIAVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status For Immediate Release ORLANDO, FL
AVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status ORLANDO, FL - December 1, 2022 - AVRA Medical Robotics, Inc. ("AVRA" or "the Company") (OTC: AVMR) today announced that as of November 30, 2022, it has filed all required periodic reports with th
Read more →SSIIAVRA Medical Robotics, Inc. (OTCMKTS: AVMR) 2020 Year-End CEO Update Letter to Shareholders and the Investment Community For Immediate Release ORLANDO, FL
Medical Robotics, Inc. (OTCMKTS: AVMR) Year-End CEO Update Letter to Shareholders and the Investment Community ORLANDO, FL - February 11, 2021 - AVRA Medical Robotics, Inc. ("AVRA" or "the Company") (OTCMKTS: AVMR) today issued the following update letter by its CEO, Barry Co
Read more →SSIIWe further remind you that AVRA files quarterly, annual and other periodic reports with the SEC. You may access all such filings through the SEC's website at www.sec.gov . Our Laboratory, Software Design Studio and Machi
95% of you have been with the AVRA TEAM and me for more than six years. You have been patient, supportive and well-wishing during these past years. Our most recent investors have been with AVRA for two years now and have supplied important help carrying our Mission to fruition.
Read more →SSIIAVRA MEDICAL ROBOTICS, INC. UPDATES SHAREHOLDERS AND THE INVESTMENT COMMUNITY WITH RESPECT TO RECENT EVENTS RAISING AVRA'S VISIBILITY IN THE MEDICAL ROBOTICS FIELD Orlando, Florida - September 21-, 2017 - AVRA Medical Ro
AVRA MEDICAL ROBOTICS, INC. UPDATES SHAREHOLDERS AND THE INVESTMENT COMMUNITY WITH RESPECT TO RECENT EVENTS RAISING AVRA'S VISIBILITY IN THE MEDICAL September 21-, 2017 - AVRA Medical Robotics, Inc. ("AVRA"), which is planning to enter the field of medical robotics through the
Read more →Competitive Position
How SSII ranks across every disease it competes inCompetitive Position is a premium feature
See how SSII ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial